A hyper-activatable CAMK2A variant associated with intellectual disability causes exaggerated long-term potentiation and learning impairments
Intellectual disability (ID) is a neurodevelopmental disorder (NDD) characterized by impairments in intellectual and adaptive functioning, and is highly co-morbid with other NDDs. Recently, de novo missense variants in the gene, CAMK2A, which encodes calcium/calmodulin-dependent protein kinase IIα (CaMKIIα), an abundant neuronal protein crucial for synaptic plasticity, learning and memory, have been implicated in ID. However, the causative impact of these mutations remains underexplored. In this study, we developed a heterozygous knock-in mouse model carrying the most prevalent ID-associated CAMK2A de novo missense variant, P212L, as a gain-of-function allele. The knock-in mice exhibited increased autophosphorylation of CaMKIIα, indicative of exuberant kinase activity, and consistently showed dendritic spine abnormalities and exaggerated hippocampal long-term potentiation induced by a subthreshold low-frequency stimulation. Furthermore, a comprehensive behavioral evaluation, including learning and memory tasks, revealed prominent phenotypes recapitulating the complex clinical phenotypes of humans with ID/NDDs harboring the same variant. Taken together, we propose that aberrant enhancement of CaMKIIα signaling by the heterozygous P212L mutation underlies a subset of ID/NDD features. These findings provide new insights into the pathogenesis of ID/NDDs, specifically through the genetic up-shifting of the critical memory regulator, CaMKII. Additionally, the established mouse model, with both construct and face validity, is expected to significantly contribute to the understanding and future therapeutic development of ID/NDDs.
Authors
- Hirokazu Hirai (ORCID: https://orcid.org/0000-0002-0721-4293)
- Hiroyuki Mizoguchi (ORCID: https://orcid.org/0000-0001-6993-4184)
- Fumiko Arima‐Yoshida
- Atsushi Yabuuchi (ORCID: https://orcid.org/0000-0003-4659-9429)
- Hajime Narita (ORCID: https://orcid.org/0009-0000-1414-7802)
- Shuhei Ueda (ORCID: https://orcid.org/0000-0001-8107-8608)
- Xinzi Liu
- Norio Ozaki (ORCID: https://orcid.org/0000-0002-7360-4898)
- Ayako M. Watabe (ORCID: https://orcid.org/0000-0002-6916-5757)
- Geyao Dong (ORCID: https://orcid.org/0000-0002-3665-7640)
- Pin-Wu Liu (ORCID: https://orcid.org/0000-0001-8053-2098)
- Ayumu Konno (ORCID: https://orcid.org/0000-0001-9382-396X)
- Haruhiko Bito (ORCID: https://orcid.org/0000-0001-6315-9594)
- Sayaka Takemoto‐Kimura (ORCID: https://orcid.org/0000-0002-2190-3191)
- Daisuke Mori (ORCID: https://orcid.org/0000-0002-9072-2546)
- Masashi Nagase
- Masahito Sawahata (ORCID: https://orcid.org/0009-0009-7635-2292)
- Hiroyuki Kidokoro (ORCID: https://orcid.org/0000-0002-7991-8580)
- Hajime Fujii
- Kiyofumi Yamada (ORCID: https://orcid.org/0000-0002-5280-5180)
- Shin-ichiro Horigane
- Yukihiro Ozawa
- Miao Pan
Institutions
- Jikei University School of Medicine (JP)
- Gunma University (JP)
- Kyoto University (JP)
- Nagoya University Hospital (JP)
- Nagoya University (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- Translational Psychiatry
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1038/s41398-025-03316-4
- Citations
- 3
- Primary Topic
- Genetics and Neurodevelopmental Disorders
- Type
- article
- Field-Weighted Citation Impact
- 5.45
Funders
- Japan Foundation for Applied Enzymology
- Japan Agency for Medical Research and Development
- Kawano Masanori Memorial Public Interest Incorporated Foundation
- Japan Society for the Promotion of Science